M89.0
Algoneurodystrophy
Clinical Classification Guidelines
Inclusion Terms
- Shoulder-hand syndrome
- Sudeck's atrophy
Excludes Type 1
- causalgia, lower limb (G57.7-)
- causalgia, upper limb (G56.4-)
- complex regional pain syndrome II, lower limb (G57.7-)
- complex regional pain syndrome II, upper limb (G56.4-)
- reflex sympathetic dystrophy (G90.5-)
Medical Intelligence & Overview
Algoneurodystrophy, also known as Sudeck's atrophy, is a chronic pain condition involving the bones, muscles, and nerves, typically affecting the limbs. It is characterized by severe, ongoing pain and various physical changes in affected tissues. The condition can develop after an injury or trauma, and it often involves a complex interplay of nerve and circulatory system dysfunctions. Although the precise cause remains unclear, understanding its symptoms, diagnosis, and potential treatments can help manage the condition more effectively.
Causes & Symptoms
Clinical Causes: Previous trauma or injury, such as fractures, sprains, or surgeries Nerve damage or abnormal nerve response following injury Immune system dysfunction contributing to inflammation Prolonged immobilization of the affected limb Infections that trigger nerve or vascular changes Psychological factors that may influence pain perception
Key Symptoms: Intense, burning pain localized to the affected limb Swelling and edema in the affected area Skin changes such as discoloration, redness, or a shiny appearance Increased hair or nail growth in the affected region Stiffness and decreased range of motion in nearby joints Temperature asymmetry between affected and unaffected limbs Muscle wasting or atrophy over time Sensory disturbances, including numbness or hypersensitivity
Diagnostic & Treatment
Diagnosis Path: Diagnosis of algoneurodystrophy involves a combination of clinical evaluation, patient history, and various tests. Physicians typically look for characteristic symptoms, especially pain out of proportion to initial injury, along with physical signs such as swelling or skin discoloration. Diagnostic imaging like X-rays may reveal bone demineralization or osteoporosis in chronic stages. Other useful assessments include nerve conduction studies and bone scans to evaluate circulatory and nerve function. Because no single test definitively identifies the condition, diagnosis often relies on ruling out other causes of limb pain and inflammation.
Treatment Protocols: Medications such as pain relievers, corticosteroids, or nerve pain medications like gabapentin Physical therapy to maintain and improve joint mobility and muscle strength Psychological support or counseling to address pain-related stress and emotional impact Nerve blocks or other invasive procedures for pain relief Sympathetic nerve blocks or neuromodulation techniques in some cases Gradual mobilization and exercises to prevent stiffness and muscle wasting Use of splints or braces to support and protect affected limbs Addressing underlying causes, such as managing inflammation or circulation issues, if identifiable
Clinical Advice & FAQs
Billing Guidance
Is M89.0 a billable ICD-10 code?
Yes, M89.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M89.0?
Clinical documentation must specify the nature of Algoneurodystrophy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference